Clinical Trials Browser

Unknown × Therapeutics × Plasma cell × Clear all

NCT03767725 2018-12-10

Anti-BCMA or/and Anti-CD19 CART Cells Treatment of Relapsed Multiple Myeloma

Phase 1 Unknown

Multiple Myeloma